Replies to post #29509 on Intellipharmaceutics International Inc. (IPCI)

[beachguy3363]

Bingo!! You said it and guess what... Schwab is back at it again begging for shares to be lent. Someone wants to finish it off or at least get price low enough to steal the company cheap! I've told you guys before how John Malone stole Sirius/Xm and Goldman did all his dirty work until his non takeover time was up. Someone either wants IPCI out or wants Odidis science cheap. One thing for sure is the end is close at hand one way or the other. Several entities have to be involved in this game though... perfect storm doesn't just happen that easy.

[fabius]

We can say many things about company's management and strategy but the shares behaviuos does show anomalies or peculiar points:

- day after AdComm was lower than 4mln shares traded (we traded much more in Oct 2016 and Feb 2017): consistent therfore with a setback instead of a failure (like in the cases of single product biotechs)

- price went down from 1.50 to below 1.00 through 11 trading days with an average volume lower than 300k shares (value of which is ridicolously low for such a big movement)

- even if we have been in oversold territory there is no sign even of a technical rebound; the price seems to have a target area which HAS to be below 1.00

- for major info about any possible shareholders moves after the AdComm we have to wait at least 45 days following the 26th of July; I would say that between 10-15th of sept we will have all the data flowing via the 13D filings (if any)

- based on what above, we could consider plausible an orchestrated movement, not necessarily by some big players (given the low volume over the period I believe 3 pc - 3 accounts and a good algorithm can accomlish the job)

We are therefore currently blind (nothing new with IPCI).

In conclusion: I am disgusted as well, but I hope company silence is preluding something good, fearing instead of being again disappointed.

All this JMHO